Sarfaraz K. Niazi, PhD, a member of The Center for Biosimilars® Advisory Board, reports on his citizen petition to… https://t.co/kuZKV8H4Jz
Archives
An inflection point for biosimilars https://t.co/N
An inflection point for biosimilars https://t.co/NKR823Pjal via @McKinsey
@Janelouisewebb @AngelMayActor I hope she gets to
@Janelouisewebb @AngelMayActor I hope she gets to the bottom of this quickly. #crohnsdisease sucks.
Mondays are the Best Days… Said nobody. UNTIL NO
Mondays are the Best Days…
Said nobody.
UNTIL NOW! 10:30pm est!
with #indiegame #cygnuspizzarace by… https://t.co/Dj1rSsPay5
@CzechTheScore My conviction wasn’t based on the
@CzechTheScore My conviction wasn’t based on the approval itself but the quality of the R&D culture in neurology at… https://t.co/unFFv2s6sL
@erggamin @HourADayGamer @Longplay_Games @Nestingd
#lupus #crohnsdisease #Fibromyalgia #autoimmunedis
@Crussunt 😂😂 True but its for people with cr
@Crussunt 😂😂
True but its for people with crohns so its special diet stuff
You are invited to learn about ongoing and upcomin
You are invited to learn about ongoing and upcoming Ulcerative Colitis and Crohn’s Disease clinical trials on Wedne… https://t.co/vh5uRc0F8V
@MedCrisis Not That big, not entirely unsolved but
@MedCrisis Not That big, not entirely unsolved but in need of more research:
ulcerative colitis/ crohns disease
Migranes
ME/CFS